MENU
TSBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Turnstone Biologics (TSBX) Ownership - Who owns Turnstone Biologics?

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors... Show more

Profile

Industry
N/A
Address
9310 Athena Circle
Phone
+1 347 897-5988
Employees
80
Web
https://www.turnstonebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.1M
P/E Ratio
N/A
Total Cash
21.85M
Projected Growth
N/A
Total Debt
690K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.94
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

TSBX
Capitalization
8.1M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
21.8M
Total Cash/Share
0.94
Total Debt
690K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
20M
P/B Ratio
0.41
Cash Flow
N/A
Earnings
-2.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
23K
Current Ratio
3.70
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-59.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-103.30
Shares Held By Institutions
4.7M
Shares Outstanding - Current
23.1M
Total Liabilities
7.63M
Total Volume MTD
N/A
Value
1
Gain YTD
-29.563
View a ticker or compare two or three
TSBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TSBX showed earnings on May 09, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
9310 Athena Circle
Phone
+1 347 897-5988
Employees
80
Web
https://www.turnstonebio.com